In the May 31, 2016, Federal Register, FDA announced an upcoming public workshop called "Sequencing Quality Control II." The public workshop is part of a new MicroArray Quality Control project called Sequencing Quality Control 2 ("SEQC2"). SEQC2 is the FDA-led communitywide consortium efforts to develop best practices with recommended standard analysis protocols and quality control metrics for whole genome sequencing and target gene sequencing technologies that will support regulatory science research and precision medicine. Sessions for the public workshop include (i) germline mutation; (ii) somatic mutation; (iii)bioinformatics challenges; and (iv) clinical application. The public workshop will be held September 13 and 14, 2016.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
